Relevant biomarkers include cytokines and targets such as IL-4, IgE, IL-5, IL-13, IL-33, and TSLP (Figure 2). A number of targeted drugs are currently available, including lebrikizumab, dupilumab, and ...

Generally speaking, when someone has Type 1 diabetes, their blood contains a marker – called islet autoantibodies – that ...

Discover how targeted therapies are revolutionizing autoimmune disease treatment by offering greater precision.